<?xml version="1.0" encoding="UTF-8"?>
<item>
    <rel_title>Rapid Detection of 2019 Novel Coronavirus SARS-CoV-2 Using a CRISPR-based DETECTR Lateral Flow Assay</rel_title>
    <rel_doi>10.1101/2020.03.06.20032334</rel_doi>
    <rel_link>http://medrxiv.org/cgi/content/short/2020.03.06.20032334</rel_link>
    <rel_abs>An outbreak of novel betacoronavirus, SARS-CoV-2 (formerly named 2019-nCoV), began in Wuhan, China in December 2019 and the COVID-19 disease associated with infection has since spread rapidly to multiple countries. Here we report the development of SARS-CoV-2 DETECTR, a rapid (~30 min), low-cost, and accurate CRISPR-Cas12 based lateral flow assay for detection of SARS-CoV-2. We validated this method using contrived reference samples and clinical samples from infected US patients and demonstrated comparable performance to the US CDC SARS-CoV-2 real-time RT-PCR assay.</rel_abs>
    <rel_authors>Broughton, J. P.; Deng, X.; Yu, G.; Fasching, C. L.; Singh, J.; Streithorst, J.; Granados, A.; Sotomayor-Gonzalez, A.; Zorn, K.; Gopez, A.; Hsu, E.; Gu, W.; Miller, S.; Pan, C.-Y.; Guevara, H.; Wadford, D.; Chen, J.; Chiu, C. Y.</rel_authors>
    <rel_date>2020-03-10</rel_date>
    <rel_site>medrxiv</rel_site>
</item>